Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 288 entries
View as:

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D956 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06281132 Org: User:
Start: 03/22/24 End: 05/14/24 Due: 05/14/25

To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT02977065 Org: User:
Start: 03/23/17 End: 01/30/18 Due: 01/30/19

A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393)

Phase: N/A Priority: Normal
NCT ID: NCT04431687 Org: User:
Start: 06/15/20 End: 10/26/20 Due: 10/26/21

CKD-330 Drug-Drug Interaction Study (Candesartan)

Phase: N/A Priority: Normal
NCT ID: NCT02064621 Org: User:
Start: 06/30/14 End: 08/31/14 Due: 08/31/15

Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314

Phase: N/A Priority: Normal
NCT ID: NCT04871646 Org: User:
Start: 06/30/21 End: 08/31/22 Due: 08/31/23

The Study to Evaluate Efficacy and Safety of MY-REPT Capsule in Primary, Liver Transplantation Recipients (MYLT1)

Phase: N/A Priority: Normal
NCT ID: NCT01766518 Org: User:
Start: 11/30/09 End: 05/31/14 Due: 05/31/15

Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT03749356 Org: User:
Start: 09/05/18 End: 12/04/20 Due: 12/04/21

A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02565368 Org: User:
Start: 07/31/15 End: 08/31/15 Due: 08/31/16

Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519

Phase: N/A Priority: Normal
NCT ID: NCT02753504 Org: User:
Start: 04/30/16 End: 07/31/16 Due: 07/31/17

Clinical Study to Evauate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04304547 Org: User:
Start: 02/04/20 End: 04/02/20 Due: 04/02/21

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348

Phase: N/A Priority: Normal
NCT ID: NCT04660370 Org: User:
Start: 01/09/21 End: 04/15/21 Due: 04/15/22

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03849495 Org: User:
Start: 02/19/19 End: 03/21/19 Due: 03/21/20

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT04651881 Org: User:
Start: 10/27/20 End: 12/09/20 Due: 12/09/21

Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03739125 Org: User:
Start: 11/07/17 End: 12/02/20 Due: 12/02/21

Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT01756937 Org: User:
Start: 01/31/13 End: 02/28/17 Due: 02/28/18

CKD-11101 Phase 3 IV Study in Patients Who Had Renal Anemia Receiving Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT03428594 Org: User:
Start: 06/30/15 End: 06/30/17 Due: 06/30/18

CKD-330 Phase 3 Trial in Amlodipine Non-responder

Phase: N/A Priority: Normal
NCT ID: NCT02586311 Org: User:
Start: 01/31/16 End: 09/30/16 Due: 09/30/17

A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

Phase: N/A Priority: Normal
NCT ID: NCT02651753 Org: User:
Start: 01/31/16 End: 05/31/16 Due: 05/31/17

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375

Phase: N/A Priority: Normal
NCT ID: NCT04221360 Org: User:
Start: 01/29/20 End: 06/08/20 Due: 06/08/21

To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06492655 Org: User:
Start: 07/04/24 End: 08/08/24 Due: 08/08/25

Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519

Phase: N/A Priority: Normal
NCT ID: NCT02894541 Org: User:
Start: 08/31/16 End: 01/31/17 Due: 01/31/18

A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT03950843 Org: User:
Start: 04/23/19 End: 12/31/21 Due: 12/31/22

Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject.

Phase: N/A Priority: Normal
NCT ID: NCT02623868 Org: User:
Start: 10/31/15 End: 12/31/15 Due: 12/31/16

CKD-337 Drug Interaction Study

Phase: N/A Priority: Normal
NCT ID: NCT02066207 Org: User:
Start: 03/18/14 End: 05/29/14 Due: 05/29/15

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378

Phase: N/A Priority: Normal
NCT ID: NCT05741437 Org: User:
Start: 04/11/23 End: 09/05/23 Due: 09/05/24